1. 1. Kim JW, Cha Y, Kim SJ, Han SW, Oh DY, Lee SH, et al. Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy. Supportive Care in Cancer 2012;20(2):395-403.2. Ramírez-Amador V, Anaya-Saavedra G, Crespo-Solís E, Irigoyen Camacho E, González-Ramírez I, Ponce-de-León S. Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy. Supportive Care in Cancer 2010;18(5):639-46.3. Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol 2017;7:89.4. Kamińska M, Juszkiewicz M, Tymicka R, Bronikowska A, Kolak A. Procedure in the prevention and nurturing of inflammatory changes of oral mucositis among patients treated for oncological conditions. Medical Studies/Studia Medyczne. 2016;32(2):145-9.5. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, et al. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010;153(6):358-67.6. Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM. Oral mucositis due to high-dose chemotherapy and/or head and neck radiation therapy. JNCI Monographs 2019;(53): lgz011.7. Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet F, Barasch A, et al. Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy. Cancer 2008;113(10):2704-13.8. Luitel A, Rimal J, Maharjan IK, Regmee P. Assessment of oral mucositis among patients undergoing radiotherapy for head and neck cancer. Kathmandu Univ Med J 2019;65(1):63-7.9. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB. Chemotherapy-associated oral sequelae in patients with cancers outside the head and neck region. J Pain Symptom Manage 2014;48(6):1060-9.10. Çakmak S, Nural N. Incidence of and risk factors for development of oral mucositis in outpatients undergoing cancer chemotherapy. Int J Nurs Pract 2019;25(1):e12710.11. Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Fusco F, et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer 2015;23(11):3249-55.12. Vokurka S, Steinerova K, Karas M, Koza V. Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. Bone Marrow Transplant. 2009;44(9):601-5.13. Staudenmaier T, Cenzer I, Crispin A, Ostermann H, Berger K. Burden of oral mucositis in stem cell transplant patients-the patients' perspective. Support Care Cancer 2018;26(5):1577-84.14. Jo KS, Kim NC. Incidence and factors influencing oral mucositis in patients with hematopoietic stem cell transplantation. J Korean Acad Nurs 2014;44(5):542-51.15. Chaudhry HM, Bruce AJ, Wolf RC, Litzow MR, Hogan WJ, Patnaik MS, et al. The incidence and severity of oral mucositis among allogeneic hematopoietic stem cell transplantation patients: a systematic review. Biol Blood Marrow Transplant 2016;22(4):605-16.16. Gussgard AM, Jokstad A, Wood R, Hope AJ, Tenenbaum H. Symptoms reported by head and neck cancer patients during radiotherapy and association with mucosal ulceration site and size: an observational study. PLoS One. 2015;10(6):e0129001.17. Shouval R, Kouniavsky L, Fein J, Danylesko I, Apel A, Shem-Tov N, et al. Determinants for oral mucositis in allogeneic hematopoietic stem cell transplantation: prospective evaluation and risk analysis. Blood. 2017
2. 3239. 18. Curra M, Soares Junior LAV, Martins MD, Santos PSDS. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (São Paulo). 2018;16(1):eRW4007 19. Urbain P, Raynor A, Bertz H, Lambert C, Biesalski HK. Role of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation. Support Care Cancer. 2012;20(8):1831-8.20. Cheng KK, Leung SF, Liang RH, Tai JW, Yeung RM, Thompson DR. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life. Support Care Cancer. 2010;18(11):1477-85.21. Bilodeau EA, Lalla RV. Recurrent oral ulceration: Etiology, classification, management, and diagnostic algorithm. Periodontology 2019;80(1):49-60.22. Leite Cavalcanti A, José de Macêdo D, Suely Barros Dantas F, dos Santos Menezes K, Filipe Bezerra Silva D, Alves de Melo Junior W, et al. Evaluation of oral mucositis occurrence in oncologic patients under antineoplastic therapy submitted to the low-level laser coadjuvant therapy. J. Clin. Med 2018;7(5):90.23. Sakellari I, Angelopoulou M, Tsopra O, Dervenoulas I, Tsirigotis P, Spyridonidis A, et al. A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation. Ann Hematol 2015;94(10):1733-40.24. Valeh M, Kargar M, Mansouri A, Kamranzadeh H, Gholami K, Heidari K, et al. Factors affecting the incidence and severity of oral mucositis following hematopoietic stem cell transplantation. Int J Hematol Oncol Stem Cell Res. 2018;12(2):142-52.25. Ohbayashi Y, Imataki O, Ohnishi H, Iwasaki A, Ogawa T, Inagaki N, et al. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Ann Hematol 2008;87(10):837-45.26. Wuketich S, Hienz SA, Marosi C. Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors. Support Care Cancer 2012;20(1):175-83.27. Martinez JM, Pereira D, Chacim S, Mesquita E, Sousa I, Martins A, et al. Mucositis care in acute leukemia and non-Hodgkin lymphoma patients undergoing high-dose chemotherapy. Support Care Cancer 2014(9):2563-928. Nishimura N, Nakano K, Ueda K, Kodaira M, Yamada S, Mishima Y, et al. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas. Support Care Cancer 2012;20(9):2053-9.29. Saedi HS, Gerami H, Soltanipour S, Habibi AF, Mirhosseyni M, Montazeri S, et al. Frequency of chemoradiotherapy-induced mucositis and related risk factors in patients with the head-and-neck cancers: A survey in the North of Iran. J. Dent. Res 2019;16(5):354-9.30. Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology. 2009;45(12):1015-20.31. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology. 2000;110(2):292-9.32. Haverman TM, Raber-Durlacher JE, Rademacher WMH, Vokurka S, Epstein JB, Huisman C, et al. Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators of inflammation 2014;2014:1-18.33. Shumsky A, Bilan E, Sanz E, Petrovskiy F. Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis. Mol Clin Oncol. 2019;10(4):463-8.34. Epstein JB, Saunders DP. Managing oral mucositis in cancer therapy. [online]. 1 Temmuz 2015. http://www.oralhealthgroup.com/features/managing-oral-mucositis-cancer-therapy. 17 Eylül 2019.35. Eduardo FdP, Bezinelli LM, Gobbi MF, Pereira AZ, Vogel C, Hamerschlak N, et al. Impact of oral and gastrointestinal mucositis on body weight alterations during hematopoietic stem cell transplantation. Nutr Cancer 2018;70(2):241-8.36. Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, et al. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer 2015;23(1):223-36.37. Gomes AOF, Silva Junior A, Noce CW, Ferreira M, Maiolino A, Torres SR. The frequency of oral conditions detected in hematology inpatients. Hematol Transfus Cell Ther 2018;40(3):240-4.38. Fanning SR, Rybicki L, Kalaycio M, Andresen S, Kuczkowski E, Pohlman B, et al. Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol. 2006;135(3):374-81.39. Franco P, Martini S, Di Muzio J, Cavallin C, Arcadipane F, Rampino M, et al. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Medical Oncology. 2017;34(5):81.40. Kuo CC, Wang RH, Wang HH, Li CH. Meta-analysis of randomized controlled trials of the efficacy of propolis mouthwash in cancer therapy-induced oral mucositis. Support Care Cancer 2018;26(12):4001-9.41. Jehn P, Stier R, Tavassol F, Dittmann J, Zimmerer R, Gellrich NC, et al. Physical and psychological impairments associated with mucositis after oral cancer treatment and their impact on quality of life. Oncol Res Treat 2019;42(6):342-8.42. Olson K, Davies B, Degner L, Neufeld K, Plummer H, Thurston N, et al. Assessing stomatitis: refinement of the Western Consortium for Cancer Nursing Research (WCCNR) stomatitis staging system. Can Oncol Nurs J. 1998;8(3):160-5.43. Baysal E, Sarı D. Hematopoetik kök hücre naklinde oral mukozitin önlemesi, bakımı ve tedavisinde güncel yaklaşımlar: Literatür incelemesi. Journal of Human Sciences 2016;13(3), 5721-39.44. Tavakoli Ardakani M, Ghassemi S, Mehdizadeh M, Mojab F, Salamzadeh J, Ghassemi S, et al. Evaluating the effect of Matricaria recutita and Mentha piperita herbal mouthwash on management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: A randomized, double blind, placebo controlled clinical trial. Complement Ther Med 2016;29:29-34.45. Sonis ST. A Comparison and Assessment of Scoring Scales for Mucositis. In: Sonis ST, editor. Oral Mucositis. Tarporley: Springer Healthcare Ltd.
3. 2012. p. 39-46.46. McGuire DB, Fulton JS, Park J, Brown CG, Correa MEP, Eilers J, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21(11):3165-77.47. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109(5):820-31.48. Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 2019;27(10):3949-67.49. Çıtlak K, Kapucu S. Kemoterapi alan hastalarda görülen oral mukozitin önlemesi ve tedavisinde güncel yaklaşımlar: Kanıta dayalı uygulamalar. HUHEMFAD-JOHUFON 2015;2(1).50. Roopashri G, Jayanthi K, Guruprasad R. Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail. Contemp. Clin. Dent. 2011;2(1):8.51. Chitapanarux I, Tungkasamit T, Petsuksiri J, Kannarunimit D, Katanyoo K, Chakkabat C, et al. Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis. Support Care Cancer 2018;26(3):879-86.52. Kazemian A, Kamian S, Aghili M, Hashemi FA, Haddad P. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care (Engl). 2009;18(2):174-8.53. Rastogi M, Khurana R, Revannasiddaiah S, Jaiswal I, Nanda SS, Gupta P, et al. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy. Support Care Cancer 2017;25(5):1439-43.54. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453-61.55. Chaveli-López B, Bagán-Sebastián JV. Treatment of oral mucositis due to chemotherapy. J Clin Exp Dent 2016;8(2):e201-e9.56. Soylu Özler G, Okuyucu Ş, Akoğlu E. The efficacy of sucralfate and chlorhexidine as an oral rinse in patients with recurrent aphthous stomatitis. Adv Med 2014;2014:986203-.57. Cardona A, Balouch A, Abdul MM, Sedghizadeh PP, Enciso R. Efficacy of chlorhexidine for the prevention and treatment of oral mucositis in cancer patients: a systematic review with meta-analyses. J Oral Pathol Med 2017;46(9):680-8.58. Kanagalingam J, Chopra A, Hong MH, Ibrahim W, Villalon A, Lin J-C. Povidone-iodine for the management of oral mucositis during cancer therapy. Oncology reviews 2017;11(2):341.59. Madan PD, Sequeira PS, Shenoy K, Shetty J. The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial. J Cancer Res Ther. 2008;4(1):3-8.60. Ala S, Saeedi M, Janbabai G, Ganji R, Azhdari E, Shiva A. Efficacy of sucralfate mouth wash in prevention of 5-fluorouracil induced oral mucositis: a prospective, randomized, double-blind, controlled trial. Nutr Cancer 2016;68(3):456-63.61. Mozaffari HR, Payandeh M, Ramezani M, Sadeghi M, Mahmoudiahmadabadi M, Sharifi R. Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials. Wspolczesna Onkol 2017;21(4):299-305.62. Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, et al. Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial. J Clin Oncol. 2011;29(20):2815-20.63. Treister N, Nieder M, Baggott C, Olson E, Chen L, Dang H, et al. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation. Br J Cancer 2016;116:21.64. Wasko-Grabowska A, Rzepecki P, Oborska S, Barzal J, Gawronski K, Mlot B, et al. Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 2011;43(8):3111-3.65. Quinn B. Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data. Eur J Cancer Care (Engl). 2013;22(5):564-79.66. Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, et al. Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. Support Care Cancer 2019;27(10):3997-4010.67. Rambod M, Pasyar N, Ramzi M. The effect of zinc sulfate on prevention, incidence, and severity of mucositis in leukemia patients undergoing chemotherapy. Eur J Oncol Nurs. 2018;33:14-21.68. Arbabi-kalati F, Arbabi-kalati F, Deghatipour M, Ansari Moghadam A. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial. Arch Iran Med 2012;15(7):413-7.69. Mansouri A, Hadjibabaie M, Iravani M, Shamshiri AR, Hayatshahi A, Javadi MR, et al. The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study. Hematol Oncol 2012;30(1), 22-26.70. Tian X, Liu X-L, Pi Y-P, Chen H, Chen W-Q. Oral zinc sulfate for prevention and treatment of chemotherapy-induced oral mucositis: a meta-analysis of five randomized controlled trials. Front Oncol 2018;8:484.71. Moslemi D, Babaee N, Damavandi M, Pourghasem M, Moghadamnia AA. Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: a double blind, randomized controlled clinical trial. Int J Radiat Res 2014;12(3):235-41.72. Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. Glutamine: Metabolism and immune function, supplementation and clinical translation. Nutrients. 2018;10(11):1564.73. Sayles C, Hickerson SC, Bhat RR, Hall J, Garey KW, Trivedi MV. Oral glutamine in preventing treatment-related mucositis in adult patients with cancer: a systematic review. Nutr Clin Pract 2016;31(2):171-9.74. Tsujimoto T, Yamamoto Y, Wasa M, Takenaka Y, Nakahara S, Takagi T, et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep 2015;33(1):33-9.75. Pathak S, Soni TP, Sharma LM, Patni N, Gupta AK. A randomized controlled trial to evaluate the role and efficacy of oral glutamine in the treatment of chemo-radiotherapy-induced oral mucositis and dysphagia in patients with oropharynx and larynx carcinoma. Cureus. 2019
4. 11 (6): e4855.76. Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2011(4):Cd000978.77. Manzi ND, Silveira R, dos Reis PED. Prophylaxis for mucositis induced by ambulatory chemotherapy: systematic review. J Adv Nurs 2016;72(4):735-46.78. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS one. 2014;9(9):e107418.79. Silva GBL, Sacono NT, Othon-Leite AF, Mendonça EF, Arantes AM, Bariani C, et al. Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers Med Sci 2015;30(1):117-26.80. Gholizadeh N, Sheykhbahaei N, Sadrzadeh-Afshar M-S. New treatment approaches of oral mucositis: a review of literature. Advances in Human Biology 2016;6(2):66.81. Park S-H, Han SH. Effect of Oral Cryotherapy for Reducing Oral mucositis in hematopoietic stem cell transplantation: a systematic review and meta-analysis. Korean J. Adult Nurs. 2018;30(4):362-75.82. Svanberg A, Öhrn K, Birgegård G. Five‐year follow‐up of survival and relapse in patients who received cryotherapy during high‐dose chemotherapy for stem cell transplantation shows no safety concerns. Eur J Cancer Care (Engl). 2012;21(6):822-8.83. Shin N, Kang Y. The effects of oral cryotherapy on oral mucositis, reactive oxygen series, inflammatory cytokines, and oral comfort in gynecologic cancer patients undergoing chemotherapy: a randomized controlled trial. J Kore Acad Nurs. 2019
5. 49 (2): 149-160. 84. Samdariya S, Lewis S, Kauser H, Ahmed I, Kumar D. A randomized controlled trial evaluating the role of honey in reducing pain due to radiation induced mucositis in head and neck cancer patients. Indian J Palliat Care 2015;21(3):268-73.85. Cho HK, Jeong YM, Lee HS, Lee YJ, Hwang SH. Effects of honey on oral mucositis in patients with head and neck Cancer: A meta-analysis. The Laryngoscope. 2015;125(9):2085-92.86. Xu JL, Xia R, Sun ZH, Sun L, Min X, Liu C, et al. Effects of honey use on the management of radio/chemotherapy-induced mucositis: a meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2016;45(12):1618-25.87. Nagi R, Patil DJ, Rakesh N, Jain S, Sahu S. Natural agents in the management of oral mucositis in cancer patients-systematic review. J Oral Biol Craniofac Res 2018;8(3):245-54.88. Raeessi MA, Raeessi N, Panahi Y, Gharaie H, Davoudi SM, Saadat A, et al. "Coffee plus Honey" versus "topical steroid" in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. BMC complementary and alternative medicine. 2014;14(1):293.89. Khanjani Pour-Fard-Pachekenari A, Rahmani A, Ghahramanian A, Asghari Jafarabadi M, Onyeka TC, Davoodi A. The effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trial. Clin Oral Investig 2019;23(4):1811-21.90. Przybylek I, Karpinski TM. Antibacterial properties of propolis. Molecules. 2019;24(11):2047.91. Dota KFD, Consolaro MEL, Svidzinski TIE, Bruschi ML. Antifungal activity of Brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. Evid Based Complement Alternat Med 2011;201953. 92. Ferreira JM, Fernandes-Silva CC, Salatino A, Negri G, Message D. New propolis type from north-east Brazil: chemical composition, antioxidant activity and botanical origin. J Sci Food Agric. 2017;97(11):3552-8.93. Kasiotis KM, Anastasiadou P, Papadopoulos A, Machera K. Revisiting greek propolis: chromatographic analysis and antioxidant activity study. Plos One. 2017;12(1):e0170077.94. Cavalcante DRR, de Oliveira PS, Góis SM, Soares AF, Cardoso JC, Padilha FF, et al. Effect of green propolis on oral epithelial dysplasia in rats. Braz J Otorhinolaryngol. 2011;77(3):278-84.95. Bolouri AJ, Pakfetrat A, Tonkaboni A, Aledavood SA, Najafi MF, Delavarian Z, et al. Preventing and therapeutic effect of propolis in radiotherapy induced mucositis of head and neck cancers: a triple-blind, randomized, placebo-controlled trial. Iran J Cancer Prev 2015;8(5).96. Piredda M, Facchinetti G, Biagioli V, Giannarelli D, Armento G, Tonini G, et al. Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial. Eur J Kanser Bakımı (Engl). 2017;26(6):1-8.97. Chaitanya NC, Muthukrishnan A, Babu DBG, Kumari CS, Lakshmi MA, Palat G, et al. Role of vitamin E and vitamin A in oral mucositis induced by cancer chemo/radiotherapy- a meta-analysis. J Clin Diagn Res 2017;11(5):4.98. Jahangard-Rafsanjani Z, Gholami K, Hadjibabaie M, Shamshiri AR, Alimoghadam K, Sarayani A, et al. The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial. Bone Marrow Transpl. 2013;48(6):832-6.99. Aghamohamamdi A, Hosseinimehr SJ. Natural products for management of oral mucositis induced by radiotherapy and chemotherapy. Integr Cancer Ther 2016;15(1):60-8.100. Puataweepong P, Dhanachai M, Dangprasert S, Sithatani C, Sawangsilp T, Narkwong L, et al. The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: A double-blind placebo-controlled study. Asian Biomed 2009;3(4):375-382. 101. Khalid N, Fawad SA, Ahmed I. Antimicrobial activity, phytochemical profile and trace minerals of black mulberry (Morus nigra L.) fresh juice. Pak. J. Bot. (Special Issue: Medicinal Plants: conservation and sustainable use) 2011;43(6):91-6.102. Demir Doğan M, Can G, Meral RJTJoA, Medicine C. Effectiveness of black mulberry molasses in prevention of radiotherapy-induced oral mucositis: a randomized controlled study in head and neck cancer patients. J Altern Complement Med. 2017;23(12):971-9.103. Harman M, Ovayolu N, Ovayolu O. The effect of three different solutions on preventing oral mucositis in cancer patients undergoing stem cell transplantation: a non-randomized controlled trial: A Turkish study-NON-RANDOMISED TRIAL. J Pak Med Assoc. 2019;69(6):811-6.104. Çubukçu NÜ, Çınar S. Kemoterapi alan kanserli hastalarda oral mukozitler önlenebilir mi? MÜSBED 2012;2(4):155-63.105. Araújo SNM, Luz MHBA, Silva GRFd, Andrade EMLR, Nunes LCC, Moura RO. Cancer patients with oral mucositis: challenges for nursing care. Rev Lat Am Enfermagem. 2015;23(2):267-74.